Table 1 Indices of diastolic dysfunction and LV remodeling

E/A ratio

1.0–2.0

< 1.0; > 2.0

< 1.0: n = 629 (54.0%); > 2.0: n = 12 (1.0%)

< 1.0: n = 505 (58.8%); > 2.0: n = 14 (1.6%)

EDT

140–220 ms

< 140 ms; > 220 ms

< 140 ms: n = 120 (10.3%); > 220 ms; n = 163 (14.0%)

< 140 ms: n = 73 (8.1%); > 220 ms; n = 188 (21.0%)

IVRT

60–110 ms

< 60 ms; > 110 ms

< 60 ms: n = 25 (2.1%); > 110 ms: n = 23 (2.0%)

< 60 ms: n = 12 (1.3%); > 110 ms: n = 29 (3.2%)

Average e’ wave

≥ 9 cm/s

< 9 cm/s

n = 184 (15.8%)

n = 125 (14.0%)

E/e’ ratio

< 8

≥ 8

n = 247 (21.2%)

n = 149 (16.6%)

LA size

< 2.2 cm/m²

Moderately enlarged: 2.2–2.79 cm/m²; severely enlarged: ≥ 2.8 cm/m²

Moderately enlarged: n = 319 (27.4%); severely enlarged: n = 26 (2.2%)

Moderately enlarged: n = 176 (19.6%); severely enlarged: n = 14 (1.6%)

LV remodeling

LV mass ≤ 95 g/m² in women or ≤ 115 g/m² in men, and RWT ≤ 0.42

Concentric remodeling: LV mass ≤ 95 g/m² in women or ≤ 115 g/m² in men, and RWT > 0.42; concentric hypertrophy: LV mass > 95 g/m² in women or > 115 g/m² in men, and RWT > 0.42; eccentric hypertrophy: LV mass > 95 g/m² in women or > 115 g/m² in men, and RWT ≤ 0.42

Concentric remodeling: n = 45 (3.9%); concentric hypertrophy: n = 40 (3.4%); eccentric hypertrophy: n = 206 (17.7%)

Concentric remodeling: n = 39 (4.4%); concentric hypertrophy: n = 35 (3.9%); eccentric hypertrophy: n = 147 (16.4%)